Search Results - "Maluf, D"

MicroRNA Profiles in Allograft Tissues and Paired Urines Associate With Chronic Allograft Dysfunction With IF/TA by Scian, M. J., Maluf, D. G., David, K. G., Archer, K. J., Suh, J. L., Wolen, A. R., Mba, M. U., Massey, H. D., King, A. L., Gehr, T., Cotterell, A., Posner, M., Mas, V.

“…Despite the advances in immunosuppression, renal allograft attrition over time remains unabated due to chronic allograft dysfunction (CAD) with interstitial…”
Get full text

MicroRNAs as Biomarkers in Solid Organ Transplantation by Mas, V. R., Dumur, C. I., Scian, M. J., Gehrau, R. C., Maluf, D. G.

“…Important progress has been made in improving short‐term outcomes in solid organ transplantation. However, long‐term outcomes have not improved during the last…”
Get full text

Optimizing Recovery, Utilization and Transplantation Outcomes for Kidneys From Small, ≤20 kg, Pediatric Donors by Maluf, D. G., Carrico, R. J., Rosendale, J. D., Perez, R. V., Feng, S.

“…The optimal balance between maximizing the number versus the outcome of transplantation utilizing kidneys from small (≤20 kg) pediatric donors remains unclear,…”
Get full text

Systems Biology in Kidney Transplantation: The Application of Multi‐Omics to a Complex Model by Bontha, S. V., Maluf, D. G., Mueller, T. F., Mas, V. R.

“…In spite of reduction of rejection rates and improvement in short‐term survival post–kidney transplantation, modest progress has occurred in long‐term graft…”
Get full text

Evaluation of Molecular Profiles in Calcineurin Inhibitor Toxicity Post–Kidney Transplant: Input to Chronic Allograft Dysfunction by Maluf, D. G., Dumur, C. I., Suh, J. L., Lee, J. K., Cathro, H. P., King, A. L., Gallon, L., Brayman, K. L., Mas, V. R.

“…The molecular basis of calcineurin inhibitor toxicity (CNIT) in kidney transplantation (KT) and its contribution to chronic allograft dysfunction (CAD) with…”
Get full text

Effects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi‐Omics Approach by Bontha, S. V., Maluf, D. G., Archer, K. J., Dumur, C. I., Dozmorov, M. G., King, A. L., Akalin, E., Mueller, T. F., Gallon, L., Mas, V. R.

“…Progressive fibrosis of the interstitium is the dominant final pathway in renal destruction in native and transplanted kidneys. Over time, the continuum of…”
Get full text

Assessment of long‐term outcomes post living liver donation highlights the importance of scientific integrity when presenting transplant registry data by Emamaullee, Juliet, Heimbach, Julie K., Olthoff, Kim M., Pomfret, Elizabeth A., Roberts, John P., Selzner, Nazia, Taner, T., Melcher, M., DiSabato, D., Pomfret, E., Jackson, W., Han, H., Montenovo, M., Testa, G, Gupta, A, Lee, S, Hashimoto, K, Kwon, D, Emond, J, Griesemer, A, Fox, A, Kaplan, A, Samstein, B, Halazun, K, Brown, R, Kubal, A, Gilroy, R, Rodriguez‐ Davalos, M, King, E, Heimbach, J, Watt, K, Florman, S, Schiano, T, Caicedo, J, Dietch, Z, Ganger, D, Kirchner, V, Anderson, B, Shapiro, J, Roberts, J, Pillai, A, Maluf, D, Martins, P.N., Sonnenday, C, Chinnakotla, S, Olthoff, K, Bittermann, T, Abt, P, Humar, A, Ganesh, S, Hernandez‐Alejandro, R, Tomiyama, K, Levstik, M, Emamaullee, J, Kaur, N, Genyk, Y, Klair, T, Yamaguchi, S, Baker, T, Kim, R, Goldaracena, N, Bambha, K, Biggins, S, Sturdevant, M, Garonzik‐Wang, J, Al‐Adra, D, Shingina, A, Alexopoulos, S, Mulligan, D, Emre, S, Liapakis, A, Rubman, S, Batra, R

“…Living donor liver transplantation has expanded in recent years, particularly in North America. As experience with this procedure has matured over the last…”
Get full text

Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function by Marsh, C.L., Kurian, S.M., Rice, J.C., Whisenant, T.C., David, J., Rose, S., Schieve, C., Lee, D., Case, J., Barrick, B., Peddi, V.R., Mannon, R.B., Knight, R., Maluf, D., Mandelbrot, D., Patel, A., Friedewald, J.J., Abecassis, M.M., First, M.R.

“…TruGraf v1 is a laboratory-developed DNA microarray-based gene expression blood test to enable proactive noninvasive serial assessment of kidney transplant…”
Get full text

Hidden Inflammatory Molecular Signatures in Graft Kidney Biopsies: Silent Markers of Graft Fate? by Maluf, D. G., Mueller, T. F., Mas, V. R.

“…This editorial highlights findings described by Modena et al (page 1982) of hidden molecular profiles of immune‐ mediated inflammation in allograft biopsies…”
Get full text

MicroRNA Signature at the Time of Clinical HCV Recurrence Associates With Aggressive Fibrosis Progression Post‐Liver Transplantation by Gehrau, R. C., Mas, V. R., Villamil, F. G., Dumur, C. I., Mehta, N. K., Suh, J. L., Maluf, D. G.

“…Diagnosis and prediction of the severity of hepatitis C virus recurrence (HCVrec) after liver transplantation (LT) remain a challenge. MicroRNAs have been…”
Get full text

Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice by First, M.R., Peddi, V.R., Mannon, R., Knight, R., Marsh, C.L., Kurian, S.M., Rice, J.C., Maluf, D., Mandelbrot, D., Patel, A., David, J., Schieve, C., Lee, D., Lewis, P., Friedewald, J.J., Abecassis, M.M., Rose, S.

“…TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant…”
Get full text

Photodynamic Therapy Provides Local Control of Cholangiocarcinoma in Patients Awaiting Liver Transplantation by Cosgrove, N. D., Al‐Osaimi, A. M., Sanoff, H. K., Morris, M. M., Read, P. W., Cox, D. G., Mann, J. A., Argo, C. K., Berg, C. L., Pelletier, S. J., Maluf, D. G., Wang, A. Y.

“…Many transplant centers use endoscopically directed brachytherapy to provide locoregional control in patients with otherwise incurable cholangiocarcinoma (CCA)…”
Get full text

Kidney Grafts From HCV-Positive Donors: Advantages and Disadvantages by Maluf, D.G, Archer, K.J, Mas, V.R

“…Abstract The Organ Procurement and Transplantation Network database (2001–2006) was reviewed for kidney transplant (KT) recipients, to evaluate the effects of…”
Get full text

Contributions of dr. louis “pepper” dehner to the art of cutaneous pathology, the first pediatric dermatopathologist by Gru, Alejandro A., M.D, Horacio Maluf, M.D

“…Abstract Dr. Louis “Pepper” Dehner has been one of the most influential surgical pathologists of the last century. Authoring more than 450 publications, he is…”
Get full text

LP17 : Novel approach for the prevention of recurrent hepatitis C in liver transplant recipients: Preliminary results from ongoing phase III trial with civacir by Terrault, N, Shrestha, R, Satapathy, S.K, O’Leary, J.G, Campsen, J, Rosenau, J, Spivey, J, Teperman, L.W, Therapondos, G, Verna, E.C, Vierling, J.M, Schiano, T.D, Sher, L, Khallafi, H, Victor, D, Bhamidimarri, K.R, Gordon, F.D, Hanish, S, Kulik, L.M, Lake-Bakaar, G, Maluf, D, Porayko, M, Bramer, S.L, Osgood, G, Chavan, S, Daelken, N

Get full text

Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list by Fisher, RA, Maluf, D, Cotterell, AH, Stravitz, T, Wolfe, L, Luketic, V, Sterling, R, Shiffman, M, Posner, M

“…:  Background:  Orthotopic liver transplantation (OLT) for patients with small hepatocellular carcinoma (HCC) is widely accepted, and the usefulness of local…”
Get full text

Hepatic Angiosarcoma and Liver Transplantation: Case Report and Literature Review by Maluf, D., Cotterell, A., Clark, B., Stravitz, T., Kauffman, H.M., Fisher, R.A.

“…Hepatic angiosarcoma is a rare malignant vascular tumor that accounts for up to 2% of all primary liver tumors. Accurate diagnosis of this tumor is difficult,…”
Get full text

Polymorphisms in cytokines and growth factor genes and their association with acute rejection and recurrence of hepatitis C virus disease in liver transplantation by Mas, VR, Fisher, RA, Maluf, DG, Archer, KJ, Contos, MJ, Mills, SA, Shiffman, ML, Wilkinson, DS, Oliveros, L, Garrett, CT, Ferreira-Gonzalez, A

“…Acute rejection (AR) and recurrence of hepatitis C virus (HCV) infection are complications after liver transplantation (LTx). Genetic factors play a role in…”
Get full text

Salvage Procedure for Unexpected Portal Vein Thrombosis in Living Donor Liver Transplantation by Maluf, D., Shim, I., Posner, M., Cotterell, A.H., Fisher, R.A.

“…Portal vein thrombosis (PVT) is considered a relative contraindication to living donor liver transplantation (LDLTx) due to technical difficulty and ethical…”
Get full text

Non‐Resective Ablation and Liver Transplantation in Patients with Cirrhosis and Hepatocellular Carcinoma (HCC): Safety and Efficacy by Maluf, D., Fisher, R. A., Maroney, T., Cotterell, A., Fulcher, A., Tisnado, J., Contos, M., Luketic, V., Stravitz, R., Shiffman, M., Sterling, R., Posner, M.

“…We investigated the efficacy of nonresective ablation techniques and the tumor‐free survival of cirrhotic patients undergoing liver transplantation for…”
Get full text